RLT-72484

N/A

Report date: 2025/01/26 16:50:47
NME

Base Information

Drug NameRLT-72484
Drug Alias Namenicotinamide N-methyltransferase inhibitor (Ridgeline Therapeutics)RLT-72484
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinamide N-methyltransferase inhibitors
TargetsNicotinamide N-methyltransferase
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Texas Medical Branch
China Registration ClassN/A

Develop Information

Active CompaniesRidgeline Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A